Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2006
06/06/2006US7056896 Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages
06/06/2006US7056894 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
06/06/2006US7056731 Sulfotransferase SULT2A1 sequence variants
06/06/2006US7056729 Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain
06/06/2006US7056724 Storing data encoded DNA in living organisms
06/06/2006US7056718 Genetic engineering; hybrid polynucleotides;
06/06/2006US7056717 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis
06/06/2006US7056714 Nucleotide sequences comprising gene coding protein associated with complex, multicomponent enzyme systems for use in biogeneration of synthetic, aromatic, aliphatic and alicyclic aldehydes and alcohols
06/06/2006US7056709 Isolation and expression of a gene for a nitrilase from Acidovorax faclilis 72W
06/06/2006US7056706 Shot-gun sequencing and amplification without cloning
06/06/2006US7056705 Multiplex PCR primer set for human glucokinase gene amplification
06/06/2006US7056704 RNA interference mediating small RNA molecules
06/06/2006US7056702 Immunoglobulin for detecting inflammation and bacterial infections in mammals
06/06/2006US7056701 Hormone and albumin fusion protein
06/06/2006US7056694 DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use
06/06/2006US7056691 Assays for identifying α-galactosidases
06/06/2006US7056676 Using labeled nucleotide; polymeras chain reaction
06/06/2006US7056675 redox systems using horseradish peroxidase; hybridization
06/06/2006US7056674 Prediction of likelihood of cancer recurrence
06/06/2006US7056673 Preservation of RNA in a biological sample
06/06/2006US7056670 Involves immobilizing a molecule, incubation with distinguishable reporter moieties, detecting incorporation of the reporter moieties, elimination of the reporter moieties
06/06/2006US7056669 Which are coupled to electrodes via conductive oligomers for detection of hybridization; site directed mutagenesis
06/06/2006US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously
06/06/2006US7056665 Measuring degradation ratios; fusion protein
06/06/2006US7056664 analyzing hybridization of deoxyribonucleic acids, ribonucleic acids or peptide nucleic acid with complementary strands which are joined to electroconductive support surfaces and to redox systems; electrochemistry
06/06/2006US7056662 Reducing the level of circulating free fatty acids by administering a compound that inhibits mal1, especially inhibiting transcription or translation of mal1
06/06/2006US7056661 Method for sequencing nucleic acid molecules
06/06/2006US7056660 in vitro diagnosis of cancer and the use of cancer cells for screening drugs having antitumor or anticarcinogenic effects comprising analyzing or determining the presence or expression in body fluid cells of cancer-specific gene that is not expressed in non-cancer cells
06/06/2006US7056659 Characterizing nucleic acids
06/06/2006US7056517 Glucosyltransferase immunogens
06/06/2006US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders
06/06/2006US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies
06/06/2006US7056504 Rationally designed heparinases derived from heparinase I and II
06/06/2006US7056332 making a suture by modifying an aqueous suspension of a nucleic acid, e.g., by capping, crosslinking, methylation, ethylation, or attachment of a protein, to form a viscous gel, which is extruded to form a filament; optionally adding a biodegradable polymer
06/06/2006CA2116980C Chimeric and/or growth-restricted flaviviruses
06/06/2006CA2053288C Expression of human apolipoproteins ai and ai-milano in yeast
06/01/2006WO2006057499A1 Cattle beta-casein gene targeting vector using homologous recombination
06/01/2006WO2006056142A1 Cpg single-strand deoxynucleotides for use as adjuvant
06/01/2006WO2005123958A3 Cd7 as biomarker and therapeutic target for psoriasis
06/01/2006WO2005118870A3 Nanoscale electronic detection system and methods for their manufacture
06/01/2006WO2005118796A3 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
06/01/2006WO2005103243A3 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
06/01/2006WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
06/01/2006WO2005076786A3 Colon carcinoma related oligonucleotides and methods of use
06/01/2006WO2005047478A3 Compositions and methods for regulation of tumor necrosis factor-alpha
06/01/2006WO2005019426A3 Gene cluster for fostriecin biosynthesis
06/01/2006WO2005012492A8 Human skin equivalents expressing exogenous polypeptides
06/01/2006WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids
06/01/2006WO2004108896A3 Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
06/01/2006US20060117416 Isolated polynucleotide which encodes a transmembrane protein with similarities to plasma membrane Na+/H+ antiporters from bacteria and fungi confering salt tolerance
06/01/2006US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
06/01/2006US20060117410 Locked nucleic acid containing heteropolymers and related methods
06/01/2006US20060117402 Controlling gene expression; genetic engineered dna; transforming plant
06/01/2006US20060117401 Method for producing aminoacids
06/01/2006US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor
06/01/2006US20060116505 Glucose and/or fructose transporter naglt1 and its gene
06/01/2006US20060116344 Remedy and preventive for diseases caused by NF-kB
06/01/2006US20060116340 Herpesvirus ribozymes and vectors
06/01/2006US20060116339 Antisense modulation of purinoreceptor p2x3
06/01/2006US20060116338 Therapeutic and diagnostic tools for proliferative and developmental disorders and as vehicles for identifying region q26.2 on a mammalian chromosome 3; gene therapy; detecting Cornelia de Lange syndrome; diagnosing neoplasia; inducing a cell to change its pattern of differentiation
06/01/2006US20060116317 Dyeing keratin material; using ninhydrin material
06/01/2006US20060115897 Compositions and methods modulating variola and vaccinia virus
06/01/2006US20060115886 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma, aspergillus
06/01/2006US20060115881 High eicosapentaenoic acid producing strains of Yarrowia lipolytica
06/01/2006US20060115877 Hyaluronate synthase gene and uses thereof
06/01/2006US20060115876 Antihemophilic factor (FVIII) muteins covalently bound to biocompatabile polyoxyethylene glycol; low-density lipoprotein receptor; pharmacokinetics; chromatography; hemophilia
06/01/2006US20060115858 Trace amine 1 receptor of the African green monkey
06/01/2006US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis
06/01/2006US20060115851 Artificial genes for use as controls in gene expression analysis systems
06/01/2006US20060115849 Screening methods
06/01/2006US20060115848 Nucleic acid end-labeling reagents
06/01/2006US20060115842 Highly sensitive homogeneous assay based on anti-Stokes' shift FRET measurement
06/01/2006US20060115839 Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof
06/01/2006US20060115836 Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis
06/01/2006US20060115835 Method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids
06/01/2006US20060115831 Map
06/01/2006US20060115829 An isolated nucleic acid sequence encoding a DNA methyltransferase-3B variant having aseleted amino acid sequence; screening for enzyme inhibitor compounds to be used as anticarcinogenic agents for, particularly, lung cancer and, more particularly, non-small cell lung cancer
06/01/2006US20060115821 Prostate specific genes and the use thereof as targets for prostate cancer therapy
06/01/2006US20060115820 Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same
06/01/2006US20060115819 Detection, identification and differentiation of eubacterial taxa using a hybridization assay
06/01/2006US20060115818 Diagnostic and therapeutic means for kidney stone related pathologies
06/01/2006US20060115816 Splice variant cannabinoid receptor (cb1b)
06/01/2006US20060115813 Intracellular signaling molecules
06/01/2006US20060115811 Cytochrome p450ra1-2 and related proteins
06/01/2006US20060115545 Methods and means for the manufacture of hyaluronan
06/01/2006US20060115498 DNA encoding an antigenic protein of Eimeria apical membrane antigen 1 and use thereof
06/01/2006US20060115496 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof
06/01/2006US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
06/01/2006US20060115484 Nucleic acid for modulating apoptosis
06/01/2006US20060115483 Receptor polypeptide and polynucleotide encoding polypeptide; anticancer agents; viricides; multiple sclerosis; antiarthritic agents; cardiovascular disorders; osteoporosis
06/01/2006US20060115482 Modifications of histone proteins as indicators of cell proliferation and differentiation
06/01/2006US20060115479 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
06/01/2006US20060115477 Neuropilin-1 inhibitors
06/01/2006US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
06/01/2006US20060115451 Modified cytokines for use in cancer therapy
06/01/2006DE102004056980A1 Verfahren zur ortsspezifischen Synthese von Biopolymeren auf festen Trägern A method for site-specific synthesis of biopolymers on solid supports
05/2006
05/31/2006EP1661905A1 Novel artificial nucleic acids of n-o bond crosslinkage type
05/31/2006EP1660884A2 Crown ether derivatives
05/31/2006EP1660687A2 Rnai-based modification of heterochromatin
05/31/2006EP1660686A2 Hpv cd8+ t-cell epitopes